Thought Leadership - News and Blog - ProPharma

Successful Tech Transfers Require Both Strong Regulatory Strategy and Execution

Written by Claudia Rohr | July 2, 2026

Tech transfers are often treated as operational projects. In reality, the success, and especially the speed, are determined much earlier: by the clarity of your data requirements and gaps, your CMC strategy, and the strength of your Module 3. Too much focus is placed on execution and not enough on whether the dossier is sufficiently consistent and complete for regulatory assessment.

A tech transfer does not create problems. It exposes them.

Missing validation reports, insufficient or non-supportive stability data, inconsistent batch histories, or incomplete comparability concepts surface immediately. This is particularly true in situations where product knowledge is fragmented or distributed, such as external transfers, global roll-outs, or legacy and in-licensed products. What looks manageable on paper often does not hold up against actual manufacturing practice.

A less visible but critical issue emerges when comparability cannot be demonstrated, and no one fully understands why. In these cases, the issue is rarely the data itself. It is the loss of knowledge behind it.
Especially in M&A-driven or external transfers, key product and process understanding often exists only implicitly. Historical decisions are poorly documented, rationales are missing, and the dossier reflects development history rather than scientific logic. When comparability fails, it is not because the product changed too much. It is because it can no longer be justified in a regulatory context.

Common Reasons Tech Transfer Projects Experience Delays

In practice, delays are rarely driven by execution alone. They start with assumptions that are not critically assessed upfront.

CDMO or API supplier selection is not always based on a thorough assessment of whether the site can actually support the transfer from a process, documentation, and data perspective. Capacity, process understanding, documentation quality, and the availability of consistent, usable data are not always sufficiently challenged upfront, creating a weak foundation that cannot be recovered later.

The same applies to CMC gap analyses. In practice, they often remain high-level and checklist-driven, without fully addressing Module 3 content or the data and analytical readiness required to support a variation. The consequences are predictable: missing data is identified late, additional studies become necessary, and timelines slip.

Why Comparability Strategy Should be Defined Early

Comparability is another critical weak point. It is still frequently treated as an afterthought instead of a design element. Comparability needs to be designed, not reconstructed. Without early clarity on what needs to be demonstrated and how, every data point becomes a discussion. This is where projects slow down, not because the science fails, but because the strategy was never defined.

At the same time, transfers are often burdened with additional changes. Container closure systems, specifications, or process optimizations are introduced in parallel, significantly increasing regulatory complexity and complicating comparability. A tech transfer is not the right place to fix everything. Stabilizing first is what enables speed.

The Importance of Early Regulatory CMC Involvement

A recurring issue across projects is the gap between functions. Manufacturing and QA define what is feasible and acceptable, while Regulatory is brought in late to justify decisions. This consistently results in justifications that are difficult to defend, inconsistent dossiers, and increased risk at submission.

Achieving both speed and success in tech transfer requires a shift in focus. A robust CMC gap analysis must be treated as a critical path activity, not a formality. Comparability strategies need to be defined upfront, not constructed retrospectively. Knowledge recovery has to be structured and deliberate. And most importantly, Regulatory CMC must be involved early enough to shape decisions, not just justify them.

Gap Analysis, submission strategy, validation approach, comparability requirements, and regional expectations should guide the transfer from the beginning.

Misaligned submission sequencing or late consideration of regional requirements can otherwise introduce unnecessary complexity. Decisions made during the transfer will shape not only approval timelines, but also future lifecycle flexibility.

Successful Tech Transfers Require Both Strategy and Execution

Regulatory is still widely treated as a downstream function. In reality, it is a key driver of predictability.

Speed in tech transfer doesn’t come from execution.

It comes from clarity of data, strategy, and product understanding.

Anything less will ultimately slow you down.